Previous 10 |
home / stock / snzzf / snzzf news
UPPSALA, SWEDEN / ACCESSWIRE / December 21, 2023 / Senzime (STO:SEZI)(OTCQX:SNZZF) Senzime, an industry leader in algorithm-based patient monitoring solutions, today announces another major US hospital system deal. A New York metropolitan area-based university hospital group has placed an initia...
--News Direct-- Senzime CEO Phillip Siberg joined Steve Darling from Proactive from the OTC studio in New York City to shed light on the innovative solutions offered by Senzime, aimed at significantly enhancing patient safety during and post-surgery through the power of advanced algorithm...
NEW YORK, Oct. 27, 2023 (GLOBE NEWSWIRE) -- OTC Markets Group Inc. (OTCQX: OTCM), operator of regulated markets for 12,000 U.S. and international securities, today announced Senzime AB (Nasdaq Stockholm: SEZI; OTCQX: SNZZF), a Swedish medical device company, has qualified to trade on the ...
News, Short Squeeze, Breakout and More Instantly...
Senzime AB Company Name:
SNZZF Stock Symbol:
OTCMKTS Market:
UPPSALA, SE / ACCESSWIRE / June 25, 2024 / Senzime (STO:SEZI)(OTCQX:SNZZF) Senzime AB (publ.) announced today that the European Patent Office (EPO) has issued a new patent protecting unique capabilities of the Senzime TetraGraph system. Every year, approximately 100 million patients receive neu...
UPPSALA, SWEDEN / ACCESSWIRE / June 7, 2024 / Senzime (STO:SEZI)(OTCQX:SNZZF) Uppsala, Sweden - Senzime AB today announced that it has secured a purchasing contract with the number one ranked children's hospital system in the United States for its TetraGraph® quantitative neuromuscular moni...
UPPSALA, SWEDEN / ACCESSWIRE / May 21, 2024 / Senzime (STO:SEZI)(OTCQX:SNZZF) In a new clinical study published in the high-impact Anesthesiology journal, a team of US-based researchers compared the accuracy and precision of commercially available neuromuscular block monitors. The study confirms...